Central Nervous system
Pharmacology · Topic 3
Source: NMC CBME Curriculum 2024 · Volume I · Pharmacology · Topic 3 · combined PDF page 176
Practice questions
- Which statement best reflects the therapeutic importance of GPCRs reported in the supplied CNS pharmacology review?
- Which receptor pair is highlighted in the supplied review in relation to Parkinson disease?
- A question asks which GPCR groups the supplied review highlights in Alzheimer disease. Which is the best answer?
- Which receptor pair is highlighted in the supplied review in connection with multiple sclerosis?
- The supplied review highlights which GPCR pair in relation to depression?
- Which disease-receptor association is correctly matched according to the supplied review?
- Which example of a GPCR heterodimer and signaling pathway is specifically described in the supplied review?
- A researcher is investigating GPCR heterodimerization. Which interpretation is most consistent with the supplied review?
- What potential advantage does the supplied review associate with developing biased GPCR ligands?
- Which statement best distinguishes allosteric modulation from the other emerging GPCR concepts listed in the supplied review?
- Which set contains only emerging GPCR signaling or pharmacology concepts specifically discussed in the supplied review?
- Which combination is identified by the supplied review as a possible direction toward personalized GPCR-based treatment?
- A team wants to investigate CNS GPCR structure and signaling using technologies highlighted in the supplied review. Which set is most appropriate?
- Which pairing of a CNS disorder and highlighted GPCR group is mismatched?
- A proposed CNS pharmacology project aims to move beyond studying GPCR monomers and to explore signaling mechanisms that may enable more selective treatment. Which approach most directly fits this aim?
- Which statement about the potential clinical use of GPCR-based biomarkers is best supported by the supplied review?
- Which statement about the review's discussion of GPCR precision pharmacology is most accurate?